MedTrace Logo

S.P.PRO LIVER POWDER is Used to Improve Liver and Metabolic Indexes in People With Non-alcoholic Fatty Liver Disease

NCT04718051 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-01-22

No results posted yet for this study

Summary

With the Westernization of the diet and insufficient exercise, Taiwan's population of obesity, diabetes, and hyperlipidemia has increased in recent years, and the prevalence of the non-alcoholic fatty liver disease has gradually increased. Although weight loss, dietary adjustments, and certain drug treatments can delay the deterioration of the disease; however, weight loss and dietary adjustment are not easy.

Conditions

Interventions

DRUG

Shen Pu Yang Gan Wan

Shen Pu Yang Gan Wan is Traditional Chinese Medicine; in addition, it has a high dose.

DRUG

Placebo

Shen Pu Yang Gan Wan is Traditional Chinese Medicine; however, it has a very low dose.

Sponsors & Collaborators

  • Sheng Pu Pharmaceutics Co., Ltd.

    collaborator UNKNOWN

  • Taipei Medical University WanFang Hospital

    lead OTHER

Principal Investigators

  • Ming Shun Wu · Taipei Municipal Wanfang Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-13
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04718051 on ClinicalTrials.gov